Tuesday, May 08, 2007

Tuesday Day 3: Groovin’ Right Along

I was intrigued by the title of this morning’s business development tract – Risky Business: Risk Reduced Models for the Biotech Industry – so I jumped ship from my finance focus and was not disappointed. What a lively and interesting dialogue by the CEO panelists (Steve Kelly – Innovive Pharma, Scott Cormack – OncoGeneX, Jay Lichter – Akesis Pharma and the very entertaining Rajesh Shrotriya – Spectrum Pharma) and moderator Robert More of Domain Associates.

Had an opportunity to speak briefly with Jack Wheeler founder of MicroPhage and new chair of the Colorado BioScience Association. Congratulations Jack!

Listened to Massachusetts Governor Deval Patrick announce his plan to make Massachusetts the global leader in life sciences by unveiling a 10 year, $1 billion investment package, the Massachusetts Life Science Strategy.

I had been aching for some science therefore I jumped into the afternoon bench-to-products tract to listen to Vaccine Development: What We Don’t Know. Was very excited to see Alex Franzusoff, co-founder and VP of R&D of Colorado-based GlobeImmune.

My exclamation point on the day, rather than attending the social, was to take advantage of the beautiful weather and finally do the two mile Human Genome Trail. It did not disappoint.

Sights and Sounds:

The HypoSurface system is a visceral display medium - a huge billboard where the screen surface physically behaves like a precisely controlled liquid: waves, patterns, logos, even text emerge and fade within its surface.

No comments: